<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Focal <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> kinase (FAK) functions downstream of integrins and growth factor receptors to promote <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell motility and invasion </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, FAK is activated by amidated gastrin, a protumorigenic hormone </plain></SENT>
<SENT sid="2" pm="."><plain>However, it is unclear how FAK receives signals from the gastrin receptor or other G-protein-coupled receptors that can promote cell motility and invasion </plain></SENT>
<SENT sid="3" pm="."><plain>The Rho <z:chebi fb="1" ids="16235">guanine</z:chebi>-nucleotide exchange factor p190RhoGEF (Rgnef) binds FAK and facilitates fibroblast focal <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> formation on fibronectin </plain></SENT>
<SENT sid="4" pm="."><plain>Here we report that Rgnef <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expression are significantly increased during <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> progression </plain></SENT>
<SENT sid="5" pm="."><plain>In human colon <z:mp ids='MP_0002038'>carcinoma</z:mp> cells, Rgnef forms a complex with FAK and upon gastrin stimulation, FAK translocates to newly-forming focal <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesions</z:e> where it facilitates tyrosine phosphorylation of paxillin. short hairpin (shRNA)-mediated knockdown of Rgnef or FAK, or pharmacological inhibition of FAK activity, is sufficient to block gastrin-stimulated paxillin phosphorylation, cell motility, and invadopodia formation in a manner dependent upon upstream cholecystokinin-2 receptor expression </plain></SENT>
<SENT sid="6" pm="."><plain>Overexpression of the C-terminal region of Rgnef (Rgnef-C, amino acid 1,279-1,582) but not Rgnef-CΔFAK (amino acid 1,302-1,582 lacking the FAK binding site) disrupted endogenous Rgnef-FAK interaction and prevented paxillin phosphorylation and cell motility stimulated by gastrin </plain></SENT>
<SENT sid="7" pm="."><plain>Rgnef-C-expressing cells formed smaller, less invasive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with reduced tyrosine phosphorylation of paxillin upon orthotopic implantation, compared with Rgnef-CΔFAK-expressing cells </plain></SENT>
<SENT sid="8" pm="."><plain>Our studies identify Rgnef as a novel regulator of colon <z:mp ids='MP_0002038'>carcinoma</z:mp> motility and invasion, and they show that a Rgnef-FAK linkage promotes colon <z:mp ids='MP_0002038'>carcinoma</z:mp> progression in vivo </plain></SENT>
</text></document>